Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Schütz-Fuhrmann, I; Rami-Merhar, B; Fröhlich-Reiterer, E; Hofer, SE; Tauschmann, M; Mader, JK; Resl, M; Kautzky-Willer, A; Winhofer-Stöckl, Y; Laimer, M; Zlamal-Fortunat, S; Weitgasser, R.
[Insulin pump therapy and continuous glucose monitoring].
Wien Klin Wochenschr. 2023; 135(Suppl 1): 53-61.
Doi: 10.1007/s00508-023-02165-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Fröhlich-Reiterer Elke
-
Mader Julia
-
Tauschmann Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- This Guideline represents the recommendations of the Austrian Diabetes Association (ÖDG) on the use of diabetes technology (insulin pump therapy; continuous glucose monitoring, CGM; hybrid closed-loop systems, HCL; diabetes apps) and access to these technological innovations for people with diabetes mellitus based on current scientific evidence.
- Find related publications in this database (Keywords)
-
Diabetes technology
-
Insulin pump therapy
-
CGM
-
Threshold-suspension
-
AID
-
Closed-loop
-
Artificial pancreas
-
Mobile apps
-
Telemedicine